SI-BONE, Inc. (SIBN)
18.08
-0.33
(-1.79%)
USD |
NASDAQ |
Oct 02, 16:00
18.08
0.00 (0.00%)
Pre-Market: 20:00
SI-BONE Gross Profit Margin (Quarterly) : 79.54% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 79.54% |
| March 31, 2026 | 79.76% |
| December 31, 2025 | 79.03% |
| September 30, 2025 | 79.84% |
| June 30, 2025 | 79.80% |
| March 31, 2025 | 79.71% |
| December 31, 2024 | 79.13% |
| September 30, 2024 | 79.09% |
| June 30, 2024 | 79.00% |
| March 31, 2024 | 78.87% |
| December 31, 2023 | 73.80% |
| September 30, 2023 | 79.30% |
| June 30, 2023 | 81.03% |
| March 31, 2023 | 81.89% |
| December 31, 2022 | 84.07% |
| September 30, 2022 | 84.23% |
| June 30, 2022 | 86.46% |
| March 31, 2022 | 86.71% |
| December 31, 2021 | 86.62% |
| September 30, 2021 | 88.88% |
| June 30, 2021 | 89.30% |
| March 31, 2021 | 89.24% |
| Date | Value |
|---|---|
| December 31, 2020 | 89.73% |
| September 30, 2020 | 87.35% |
| June 30, 2020 | 84.93% |
| March 31, 2020 | 88.51% |
| December 31, 2019 | 89.67% |
| September 30, 2019 | 89.93% |
| June 30, 2019 | 90.27% |
| March 31, 2019 | 89.82% |
| December 31, 2018 | 91.15% |
| September 30, 2018 | 90.88% |
| December 31, 2017 | 91.15% |
| September 30, 2017 | 88.63% |
| June 30, 2017 | 89.81% |
| March 31, 2017 | 87.45% |
| March 31, 2016 | 87.98% |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 82.84% |
| December 31, 2014 | 78.66% |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 88.55% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.30% |
| Return on Assets | -6.12% |
| Return on Invested Capital | -6.79% |
| Profit Margin (Quarterly) | -7.30% |
| Operating Margin (Quarterly) | -8.58% |
| Return on Net Operating Assets | -16.24% |